RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012 · see citing works

RAGE Mediates a Novel Proinflammatory Axis

Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864 · see citing works

RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,426 · see citing works

Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E., Frosch, M., Eckman, C., Tanzi, R., Selkoe, D., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0230450100 · Cited by 1,361 · see citing works

ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease

Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303 · see citing works

Untitled work

Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284 · see citing works

Mechanisms of Neuronal Degeneration in Alzheimer's Disease

Yankner, B. A. (1996) · Neuron · doi:10.1016/s0896-6273(00)80115-4 · Cited by 947 · see citing works

Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease

Du, H., Guo, L., Fang, F., Chen, D., Sosunov, A. A., McKhann, G. M., Yan, Y., Wang, C., Zhang, H., Molkentin, J. D., et al. (2008) · Nature Medicine · doi:10.1038/nm.1868 · Cited by 935 · see citing works

Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915 · see citing works

Microglial response to amyloid plaques in APPsw transgenic mice.

Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B. T., Saido, T. C., Hsiao, K., & Cole, G. M. (1998) · Europe PMC (PubMed Central) · Cited by 592 · see citing works

Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice

Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Hanke, A., Dewachter, I., Kuiperi, C., O'Banion, K., Klockgether, T., Van Leuven, F., & Landreth, G. E. (2005) · Brain · doi:10.1093/brain/awh452 · Cited by 565 · see citing works

Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway

Li, Y., Liu, L., Barger, S. W., & Griffin, W. S. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01605.2003 · Cited by 563 · see citing works

Intrathecal inflammation precedes development of Alzheimer's disease

Tarkowski, E. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1200 · Cited by 501 · see citing works

Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure

Haq, S., Choukroun, G. J., Lim, H. S., Tymitz, K. M., del Monte, F., Gwathmey, J. K., Grazette, L. P., Michael, A., Hajjar, R. J., Force, T. L., et al. (2001) · Circulation · doi:10.1161/01.cir.103.5.670 · Cited by 440 · see citing works

Involvement of Microglial Receptor for Advanced Glycation Endproducts (RAGE) in Alzheimer's Disease: Identification of a Cellular Activation Mechanism

Lue, L.-F., Walker, D. G., Brachova, L., Beach, T. G., Rogers, J., Schmidt, A. M., Stern, D. M., & Yan, S. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7732 · Cited by 439 · see citing works

Amyloid-β peptide–Receptor for Advanced Glycation Endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease

Yan, S. D., Zhu, H., Fu, J., Yan, S. F., Roher, A. E., Tourtellotte, W. W., Rajavashisth, T. B., Chen, X., Godman, G. C., Stern, D. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5296 · Cited by 427 · see citing works

Tumor Necrosis Factor-α, Interleukin-1β, and Interferon-γ Stimulate γ-Secretase-mediated Cleavage of Amyloid Precursor Protein through a JNK-dependent MAPK Pathway

Liao, Y.-F., Wang, B.-J., Cheng, H.-T., Kuo, L.-H., & Wolfe, M. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402034200 · Cited by 389 · see citing works

p38 Kinase Is Activated in the Alzheimer's Disease Brain

Hensley, K., Floyd, R. A., Zheng, N., Nael, R., Robinson, K. A., Nguyen, X., Pye, Q. N., Stewart, C. A., Geddes, J., Markesbery, W. R., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722053.x · Cited by 373 · see citing works

Interferon-γ and Tumor Necrosis Factor-α Regulate Amyloid-β Plaque Deposition and β-Secretase Expression in Swedish Mutant APP Transgenic Mice

Yamamoto, M., Kiyota, T., Horiba, M., Buescher, J. L., Walsh, S. M., Gendelman, H. E., & Ikezu, T. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060378 · Cited by 367 · see citing works

Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathology

Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J. V., Lin, A. H., Crews, L., Tremblay, P., Mathews, P., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27341 · Cited by 355 · see citing works

Association of Microglia with Amyloid Plaques in Brains of APP23 Transgenic Mice

Stalder, M., Phinney, A., Probst, A., Sommer, B., Staufenbiel, M., & Jucker, M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65423-5 · Cited by 345 · see citing works

Role of inflammation in neurodegenerative diseases

Minghetti, L. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000169752.54191.97 · Cited by 335 · see citing works

RAGE potentiates Aβ‐induced perturbation of neuronal function in transgenic mice

Arancio, O., Zhang, H. P., Chen, X., Lin, C., Trinchese, F., Puzzo, D., Liu, S., Hegde, A. N., Yan, S. F., Stern, A., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600415 · Cited by 328 · see citing works

The Biology of p38 Kinase: A Central Role in Inflammation

Schieven, G. L. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026054985902 · Cited by 314 · see citing works

Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice

Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Dewachter, I., Walter, J., Klockgether, T., & Van Leuven, F. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-22 · Cited by 309 · see citing works

Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid Deposition

Savage, M. J., Lin, Y.-G., Ciallella, J. R., Flood, D. G., & Scott, R. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03376.2002 · Cited by 291 · see citing works

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?

Andersen, K., Launer, L. J., Ott, A., Hoes, A. W., Breteler, M. M. B., & Albert Hofman, D. (1995) · Neurology · doi:10.1212/wnl.45.8.1441 · Cited by 284 · see citing works

Interleukin-1 mediates Alzheimer and Lewy body pathologies

Griffin, W. S. T., Liu, L., Li, Y., Mrak, R. E., & Barger, S. W. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-5 · Cited by 262 · see citing works

ABAD enhances Aβ‐induced cell stress via mitochondrial dysfunction

Takuma, K., Yao, J., Huang, J., Xu, H., Chen, X., Luddy, J. S., Trillat, A., Stern, D. M., Arancio, O., & Yan, S. S. (2005) · The FASEB Journal · doi:10.1096/fj.04-2582fje · Cited by 254 · see citing works

Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer’s disease

Sasaki, N., Toki, S., Chowei, H., Saito, T., Nakano, N., Hayashi, Y., Takeuchi, M., & Makita, Z. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03075-4 · Cited by 253 · see citing works

β-Amyloid-Stimulated Microglia Induce Neuron Death via Synergistic Stimulation of Tumor Necrosis Factor α and NMDA Receptors

Floden, A. M., Li, S., & Combs, C. K. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4998-04.2005 · Cited by 246 · see citing works

Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain

Giulian, D., Haverkamp, L. J., Li, J., Karshin, W. L., Yu, J., Tom, D., Li, X., & Kirkpatrick, J. B. (1995) · Neurochemistry International · doi:10.1016/0197-0186(95)00067-i · Cited by 242 · see citing works

Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model

Du, H., Guo, L., Zhang, W., Rydzewska, M., & Yan, S.-D. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.03.003 · Cited by 230 · see citing works

Immune reactive cells in senile plaques and cognitive decline in Alzheimer’s disease

Vehmas, A. K., Kawas, C. H., Stewart, W. F., & Troncoso, J. C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00090-8 · Cited by 230 · see citing works

Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition

Javadov, S. A. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00365-x · Cited by 225 · see citing works

A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model

Munoz, L., Ranaivo, H. R., Roy, S. M., Hu, W., Craft, J. M., McNamara, L. K., Chico, L. W., Van Eldik, L. J., & Watterson, D. M. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-21 · Cited by 224 · see citing works

Inflammation, anti-inflammatory agents and Alzheimer disease: The last 12 years

McGeer, P. L., Rogers, J., & McGeer, E. G. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s330 · Cited by 222 · see citing works

P38 MAP kinase is activated at early stages in Alzheimer's disease brain

Sun, A. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00180-8 · Cited by 219 · see citing works

β-Amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1

Giri, R., Shen, Y., Stins, M., Du Yan, S., Schmidt, A. M., Stern, D., Kim, K.-S., Zlokovic, B., & Kalra, V. K. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.6.c1772 · Cited by 218 · see citing works

β-Amyloid-Induced Inflammation and Cholinergic Hypofunction in the Rat Brain in Vivo: Involvement of the p38MAPK Pathway

Giovannini, M. G., Scali, C., Prosperi, C., Bellucci, A., Vannucchi, M. G., Rosi, S., Pepeu, G., & Casamenti, F. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0538 · Cited by 214 · see citing works

RAGE: A Potential Target for Aβ-Mediated Cellular Perturbation in Alzheimers Disease

Yan, S. F., Chen, X., Walker, D. G., Schmidt, A. M., Arancio, O., & Lue, L. (2007) · Current Molecular Medicine · doi:10.2174/156652407783220741 · Cited by 207 · see citing works

Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-β-Mediated Cortical Synaptic Dysfunction

Origlia, N., Righi, M., Capsoni, S., Cattaneo, A., Fang, F., Stern, D. M., Chen, J. X., Schmidt, A. M., Arancio, O., Yan, S. D., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0204-08.2008 · Cited by 200 · see citing works

Hippocampal RAGE immunoreactivity in early and advanced Alzheimer’s disease

Miller, M. C., Tavares, R., Johanson, C. E., Hovanesian, V., Donahue, J. E., Gonzalez, L., Silverberg, G. D., & Stopa, E. G. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.124 · Cited by 194 · see citing works

Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture

Giulian, D., Li, J., Leara, B., & Keenen, C. (1994) · Neurochemistry International · doi:10.1016/0197-0186(94)90066-3 · Cited by 181 · see citing works

Dynamic Complexity of the Microglial Activation Response in Transgenic Models of Amyloid Deposition: Implications for Alzheimer Therapeutics

Morgan, D., Gordon, M. N., Tan, J., Wilcock, D. M., & Rojiani, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000178444.33972.e0 · Cited by 174 · see citing works

Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration

Pei, J.-J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., & Cowburn, R. F. (2001) · Journal of Alzheimer's Disease · doi:10.3233/jad-2001-3107 · Cited by 165 · see citing works

Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures

Lue, L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00311-6 · Cited by 165 · see citing works

Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain

SWATTON, J. E., Sellers, L. A., Faull, R. L. M., Holland, A. J., Iritani, S., & Bahn, S. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03365.x · Cited by 158 · see citing works

Activation of MKK6, an upstream activator of p38, in Alzheimer's disease

Zhu, X.-W., Rottkamp, C., Hartzler, A., Sun, Z., Takeda, A., Boux, H., Shimohama, S., Perry, G., & Smith, M. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00597.x · Cited by 151 · see citing works

Glia Proinflammatory Cytokine Upregulation as a Therapeutic Target for Neurodegenerative Diseases: Function‐Based and Target‐Based Discovery Approaches

Eldik, L. J. V., Thompson, W. L., Ranaivo, H. R., Behanna, H. A., & Watterson, D. M. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82015-0 · Cited by 141 · see citing works

Glia as a Therapeutic Target: Selective Suppression of Human Amyloid-β-Induced Upregulation of Brain Proinflammatory Cytokine Production Attenuates Neurodegeneration

Ranaivo, H. R., Craft, J. M., Hu, W., Guo, L., Wing, L. K., Eldik, L. J. V., & Watterson, D. M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4652-05.2006 · Cited by 137 · see citing works

Overexpression of Monocyte Chemotactic Protein-1/CCL2 in β-Amyloid Precursor Protein Transgenic Mice Show Accelerated Diffuse β-Amyloid Deposition

Yamamoto, M., Horiba, M., Buescher, J. L., Huang, D., Gendelman, H. E., Ransohoff, R. M., & Ikezu, T. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62364-4 · Cited by 137 · see citing works

Site-Specific Blockade of RAGE-V_dPrevents Amyloid-β Oligomer Neurotoxicity

Sturchler, E., Galichet, A., Weibel, M., Leclerc, E., & Heizmann, C. W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4878-07.2008 · Cited by 136 · see citing works

RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways

Rong, L., Yan, S., Wendt, T., Hans, D., Pachydaki, S. I., Bucciarelli, L. G., Adebayo, A., Qu, W., Lu, Y., Kostov, K., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-1900com · Cited by 136 · see citing works

Inflammation occurs early during the Aβ deposition process in TgCRND8 mice

Dudal, S., Krzywkowski, P., Paquette, J., Morissette, C., Lacombe, D., Tremblay, P., & Gervais, F. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.008 · Cited by 135 · see citing works

Mitochondrial dysfunction and Alzheimer's disease: role of amyloid‐β peptide alcohol dehydrogenase (ABAD)

Yan, S. D., & Stern, D. M. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00427.x · Cited by 131 · see citing works

Preventing Activation of Receptor for Advanced Glycation Endproducts in Alzheimers Disease

Lue, L.-F., Yan, S. D., Stern, D. F., & Walker, D. G. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007054038210 · Cited by 126 · see citing works

RAGE regulates BACE1 and Aβ generation via NFAT1 activation in Alzheimer's disease animal model

Cho, H. J., Son, S. M., Jin, S. M., Hong, H. S., Shin, D. H., Kim, S. J., Huh, K. H., & Mook‐Jung, I. (2009) · The FASEB Journal · doi:10.1096/fj.08-126383 · Cited by 124 · see citing works

Autoimmunity in Alzheimer’s disease: increased levels of circulating IgGs binding Aβ and RAGE peptides

Mruthinti, S., Buccafusco, J. J., Hill, W., Waller, J. L., Jackson, T. W., ZAMRINI, E. Y., & Schade, R. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.11.001 · Cited by 113 · see citing works

The p38 MAP kinase signaling pathway in Alzheimer's disease

Johnson, G. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00268-1 · Cited by 106 · see citing works

Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: Statistical reliability and functional correlation

Blalock, E. M., Chen, K.-C., Stromberg, A. J., Norris, C. M., Kadish, I., Kraner, S. D., Porter, N. M., & Landfield, P. W. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.06.006 · Cited by 102 · see citing works

Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human β-amyloid

Craft, J. M., Watterson, D. M., Hirsch, E., & Van Eldik, L. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-15 · Cited by 96 · see citing works

Effect of endothelial cell polarity on β-amyloid-induced migration of monocytes across normal and AD endothelium

Giri, R. K., Selvaraj, S. K., Miller, C. A., Hofman, F. M., Yan, S. D., Stern, D. M., Zloković, B. V., & Kalra, V. K. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00293.2001 · Cited by 93 · see citing works

Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases

Walker, D. G., & Lue, L.-F. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20484 · Cited by 87 · see citing works

Activated Microglial Cells Are Colocalized With Perivascular Deposits of Amyloid-β Protein in Alzheimer’s Disease Brain

Uchihara, T., Akiyama, H., Kondo, H., & Ikeda, K. (1997) · Stroke · doi:10.1161/01.str.28.10.1948 · Cited by 79 · see citing works

Microglia repetitively isolated from in vitro mixed glial cultures retain their initial phenotype

Floden, A. M., & Combs, C. K. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.04.018 · Cited by 74 · see citing works

Inflammation and Alzheimer disease: The good, the bad and the ugly

Weninger, S. C., & Yankner, B. A. (2001) · Nature Medicine · doi:10.1038/87839 · Cited by 69 · see citing works

Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology

van Groen, T., & Kadish, I. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.026 · Cited by 64 · see citing works

Immune cells may fend off Alzheimer disease

Britschgi, M., & Wyss‐Coray, T. (2007) · Nature Medicine · doi:10.1038/nm0407-408 · Cited by 60 · see citing works

RAGE: A journey from the complications of diabetes to disorders of the nervous system – striking a fine balance between injury and repair

Rong, L., Gooch, C. L., Szabolcs, M., Herold, K. C., Lalla, E., Hays, A. P., Yan, S. F., Yan, S. S. D., & Schmidt, A. M. (2005) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2005-00322 · Cited by 59 · see citing works

Modeling Alzheimer's disease immune therapy mechanisms: Interactions of human postmortem microglia with antibody‐opsonized amyloid beta peptide

Lue, L., & Walker, D. G. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10422 · Cited by 55 · see citing works

Aβ-Dependent Inhibition of LTP in Different Intracortical Circuits of the Visual Cortex: The Role of RAGE

Origlia, N., Capsoni, S., Cattaneo, A., Fang, F., Arancio, O., Yan, S. D., & Domenici, L. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1045 · Cited by 54 · see citing works

Stress kinases involved inTau phosphorylation in alzheimer’s disease, tauopathies and APP transgenic mice

Ferrer, I. (2004) · Neurotoxicity Research · doi:10.1007/bf03033283 · Cited by 53 · see citing works

P38 Activation Mediates Amyloid-β Cytotoxicity

Zhu, X., Mei, M. G., Lee, H., Wang, Y., Han, J., Perry, G. L., & Smith, M. A. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6872-x · Cited by 43 · see citing works

Anti-RAGE and A Immunoglobulin Levels Are Related to Dementia Level and Cognitive Performance

Wilson, J. S., Mruthinti, S., Buccafusco, J. J., Schade, R., Mitchell, M. B., Harrell, D., Gulati, N. K., & Miller, L. S. (2009) · The Journals of Gerontology Series A · doi:10.1093/gerona/gln002 · Cited by 31 · see citing works

Autoimmunity in Alzheimers Disease as Evidenced by Plasma Immunoreactivity Against RAGE and Aβ42: Complication of Diabetes

Mruthinti, S., Schade, R., Harrell, D., Gulati, N., Swamy-Mruthinti, S., Lee, G., & Buccafusco, J. J. (2006) · Current Alzheimer Research · doi:10.2174/156720506777632899 · Cited by 28 · see citing works

Overexpression of receptor of advanced glycation end products hypersensitizes cells for amyloid beta peptide-induced cell death

Hadding, A., Kaltschmidt, B., & Kaltschmidt, C. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.01.003 · Cited by 25 · see citing works

The induction of surface β-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products

Mruthinti, S., Sood, A., Humphrey, C., Swamy-Mruthinti, S., & Buccafusco, J. J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.06.010 · Cited by 21 · see citing works

Relationship Between the Induction of RAGE Cell-Surface Antigen and the Expression of Amyloid Binding Sites

Mruthinti, S., Hill, W., Swamy-Mruthinti, S., & Buccafusco, J. J. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:223 · Cited by 17 · see citing works

Cytotoxicity of Aβ 1-42, RAGE23-54, and An Aβ -RAGE Complex in PC-12 Cells

Mruthinti, S., Capito, N., Sood, A., & Buccafusco, J. J. (2007) · Current Alzheimer Research · doi:10.2174/156720507783018325 · Cited by 12 · see citing works

Sterile inflammation: sensing and reacting to damage

Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051 · see citing works

Microglia development and function

Nayak, D., Roth, T. L., & McGavern, D. B. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120240 · Cited by 1,154 · see citing works

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease

Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994 · see citing works

Inflammaging and ‘Garb-aging’

Franceschi, C., Garagnani, P., Vitale, G., Capri, M., & Salvioli, S. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.09.005 · Cited by 997 · see citing works

The biphasic function of microglia in ischemic stroke

Ma, Y., Wang, J., Wang, Y., & Yang, G. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.005 · Cited by 724 · see citing works

Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease

Pugazhenthi, S., Qin, L., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.04.017 · Cited by 697 · see citing works

Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons

Rajmohan, R., & Reddy, P. H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160612 · Cited by 695 · see citing works

RAGE regulation and signaling in inflammation and beyond

Kierdorf, K., & Fritz, G. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1012519 · Cited by 434 · see citing works

Diesel Exhaust Activates and Primes Microglia: Air Pollution, Neuroinflammation, and Regulation of Dopaminergic Neurotoxicity

Levesque, S., Taetzsch, T., Lull, M. E., Kodavanti, U., Stadler, K., Wagner, A., Johnson, J. A., Duke, L., Kodavanti, P., Surace, M. J., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002986 · Cited by 371 · see citing works

Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases

Byun, K., Yoo, Y., Son, M., Lee, J., Jeong, G.-B., Park, Y. M., Salekdeh, G. H., & Lee, B. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.030 · Cited by 357 · see citing works

Microglia Function in Alzheimer’s Disease

Solito, E., & Sastre, M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00014 · Cited by 347 · see citing works

Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis

Doens, D., & Fernández, P. L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-48 · Cited by 348 · see citing works

The role of neuroimmune signaling in alcoholism

Crews, F. T., Lawrimore, C. J., Walter, T. J., & Coleman, L. G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.031 · Cited by 321 · see citing works

Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging

Fournet, M., Bonté, F., & Desmoulière, A. (2018) · Aging and Disease · doi:10.14336/ad.2017.1121 · Cited by 300 · see citing works

Oxidative stress and β-amyloid protein in Alzheimer’s disease

Cai, Z., Zhao, B., & Ratka, A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8155-9 · Cited by 279 · see citing works

Inflammation-Mediated Memory Dysfunction and Effects of a Ketogenic Diet in a Murine Model of Multiple Sclerosis

Kim, D. Y., Hao, J., Liu, R.-L., Turner, G., Shi, F.-D., & Rho, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035476 · Cited by 261 · see citing works

Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting

Paudel, Y. N., Angelopoulou, E., Piperi, C., Othman, I., Aamir, K., & Shaikh, M. F. (2020) · Cells · doi:10.3390/cells9020383 · Cited by 257 · see citing works

Aging of Cerebral White Matter

Liu, H., Yang, Y.-Y., Xia, Y., Zhu, W., Leak, R., Wei, Z., Wang, J.-Y., & Hu, X.-M. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.11.006 · Cited by 249 · see citing works

The inhalation anesthetic isoflurane increases levels of proinflammatory TNF-α, IL-6, and IL-1β

Wu, X., Lu, Y., Dong, Y., Zhang, G., Zhang, Y., Xu, Z., Culley, D. J., Crosby, G. J., Marcantonio, E. R., Tanzi, R. E., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.11.002 · Cited by 261 · see citing works

Microglial Aβ Receptors in Alzheimer’s Disease

Yu, Y., & Ye, R. D. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0101-6 · Cited by 247 · see citing works

Pathophysiology of RAGE in inflammatory diseases

Dong, H., Zhang, Y., Huang, Y., & Deng, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.931473 · Cited by 245 · see citing works

Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature

Carnevale, D., Mascio, G., D'Andrea, I., Fardella, V., Bell, R. D., Branchi, I., Pallante, F., Zlokovic, B., Yan, S. S., & Lembo, G. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.195511 · Cited by 241 · see citing works

Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases

Chuah, Y. K., Basir, R., Talib, H., Tie, T. H., & Nordin, N. (2013) · International Journal of Inflammation · doi:10.1155/2013/403460 · Cited by 243 · see citing works

Vitamin D cell signalling in health and disease

Berridge, M. J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.008 · Cited by 214 · see citing works

AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation

Li, X., Lv, B.-L., Xie, J., Liu, J., Zhou, X., & Wang, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.003 · Cited by 207 · see citing works

Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease

Al-Ghraiybah, N. F., Wang, J., Alkhalifa, A. E., Roberts, A. B., Raj, R., Yang, E., & Kaddoumi, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810572 · Cited by 204 · see citing works

Innate Immunity and Neuroinflammation

Shastri, A., Bonifati, D. M., & Kishore, U. (2013) · Mediators of Inflammation · doi:10.1155/2013/342931 · Cited by 201 · see citing works

Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties

Lee, Y., Choi, D., Yun, Y., Han, S., Oh, K., & Hong, J. T. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.06.011 · Cited by 195 · see citing works

Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease

Galasko, D. R., Bell, J. S., Mancuso, J. Y., Kupiec, J. W., Sabbagh, M. N., van Dyck, C. H., Thomas, R. G., Aisen, P. S. S., & Study, F. T. A. D. C. (2014) · Neurology · doi:10.1212/wnl.0000000000000364 · Cited by 187 · see citing works

Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy

Carrano, A., Hoozemans, J. J. M., van der Vies, S. M., van Horssen, J., de Vries, H. E., & Rozemuller, A. J. M. (2012) · Neurodegenerative Diseases · doi:10.1159/000334916 · Cited by 186 · see citing works

High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products

Mazarati, A. M., Maroso, M., Iori, V., Vezzani, A., & Carli, M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.012 · Cited by 182 · see citing works

The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging

Teissier, T., & Boulanger, É. (2019) · Biogerontology · doi:10.1007/s10522-019-09808-3 · Cited by 177 · see citing works

Glycation exacerbates the neuronal toxicity of β-amyloid

Li, X.-H., Du, L.-L., Cheng, X.-S., Jiang, X., Zhang, Y., Lv, B.-L., Liu, R., Wang, J.-Z., & Zhou, X.-W. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.180 · Cited by 178 · see citing works

Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer's-like disease in rats

Hussien, H. M., Abd-Elmegied, A., Ghareeb, D. A., Hafez, H. S., Ahmed, H. E. A., & Moneam, N. M. A. E. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.11.025 · Cited by 176 · see citing works

Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses

(2024) · aging and disease · doi:10.14336/ad.2023.0608 · Cited by 183 · see citing works

Innate immune activation in neurodegenerative diseases

Castro‐Gomez, S., & Heneka, M. T. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.010 · Cited by 167 · see citing works

Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model

Fang, F., Chen, X., Huang, T., Lue, L., Luddy, J. S., & Yan, S. S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.004 · Cited by 160 · see citing works

Toll-like receptor signaling and stages of addiction

Crews, F. T., Walter, T. J., Coleman, L. G., & Vetreno, R. P. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4560-6 · Cited by 159 · see citing works

Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia

Eshraghi, M., Adlimoghaddam, A., Mahmoodzadeh, A., Sharifzad, F., Yasavoli-Sharahi, H., Lorzadeh, S., Albensi, B. C., & Ghavami, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073330 · Cited by 158 · see citing works

Gram-negative bacteria and their lipopolysaccharides in Alzheimer’s disease: pathologic roles and therapeutic implications

Kim, H. S., Kim, S., Shin, S. J., Park, Y. H., Nam, Y., Lee, K. W., Lee, K. W., Kim, S., Yang, H. D., Yang, H. D., et al. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00273-y · Cited by 161 · see citing works

RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis

Ray, R., Juranek, J. K., & Rai, V. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.12.006 · Cited by 145 · see citing works

Sepsis-associated brain injury: underlying mechanisms and potential therapeutic strategies for acute and long-term cognitive impairments

Sekino, N., Selim, M. H., & Shehadah, A. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02464-4 · Cited by 141 · see citing works

Microglial activation states and their implications for Alzheimer's Disease

Valiukas, Z., Tangalakis, K., Apostolopoulos, V., & Feehan, J. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2024.100013 · Cited by 155 · see citing works

Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review

Berlanga‐Acosta, J., Guillén, G. E., Rodríguez-Rodríguez, N., Bringas-Vega, M. L., García-del-Barco-Herrera, D., Berlanga-Saez, J. O., Ojalvo, A. G., Valdés-Sosa, M. J., & Valdes-Sosa, P. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.560375 · Cited by 139 · see citing works

Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline

Little, K., Llorián‐Salvador, M., Scullion, S., Hernández, C., Simó‐Servat, O., del Marco, À., Bosma, E. K., Vargas-Soria, M., Carranza-Naval, M. J., Bergen, T. V., et al. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.10.008 · Cited by 136 · see citing works

Neurobiology of microglial action in CNS injuries: Receptor-mediated signaling mechanisms and functional roles

Hu, X., Liou, A. K. F., Leak, R. K., Xu, M., An, C., Suenaga, J., Shi, Y., Gao, Y., Zheng, P., & Chen, J. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.06.002 · Cited by 131 · see citing works

Neuroanatomical Correlates of Dysglycemia in Young Children With Type 1 Diabetes

Marzelli, M., Mazaika, P. K., Barnea‐Goraly, N., Hershey, T. G., Tsalikian, E., Tamborlane, W. V., Mauras, N., White, N. H., Buckingham, B. A., Beck, R. W., et al. (2013) · Diabetes · doi:10.2337/db13-0179 · Cited by 130 · see citing works

Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention

Zhang, G., Wang, Z., Hu, H., Zhao, M., & Sun, L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.749587 · Cited by 132 · see citing works

Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus

Zhang, J., Zhen, Y., Pu-Bu-Ci-Ren, Song, L.-G., Kong, W.-N., Shao, T.-M., Li, X., & Xi-qing, C. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.037 · Cited by 129 · see citing works

Microglial phagocytosis in aging and Alzheimer's disease

Gabandé‐Rodríguez, E., Keane, L., & Capasso, M. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24419 · Cited by 127 · see citing works

Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology

Parrott, J. M., & O’Connor, J. C. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00116 · Cited by 123 · see citing works

The role of innate immunity in Alzheimer's disease

Ennerfelt, H. E., & Lukens, J. R. (2020) · Immunological Reviews · doi:10.1111/imr.12896 · Cited by 121 · see citing works

Recent Advances in the Treatment of Alzheimer’s Disease Using Nanoparticle-Based Drug Delivery Systems

Poudel, P., & Park, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040835 · Cited by 124 · see citing works

Inhibiting TLR2 activation attenuates amyloid accumulation and glial activation in a mouse model of Alzheimer’s disease

McDonald, C. L., Hennessy, E., Rubio-Araiz, A., Keogh, B., McCormack, W., McGuirk, P., Reilly, M., & Lynch, M. A. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.07.143 · Cited by 108 · see citing works

Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer’s disease

Choi, B.-R., Cho, W.-H., Kim, J., Lee, H. J., Chung, C., Jeon, W. K., & Han, J.-S. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.147 · Cited by 111 · see citing works

Microglial Receptor for Advanced Glycation End Product-Dependent Signal Pathway Drives β-Amyloid-Induced Synaptic Depression and Long-Term Depression Impairment in Entorhinal Cortex

Origlia, N., Bonadonna, C., Rosellini, A., Leznik, E., Arancio, O., Yan, S. S., & Domenici, L. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2127-10.2010 · Cited by 111 · see citing works

The role of neutrophil granule proteins in neuroinflammation and Alzheimer’s disease

Stock, A. J., Kasus‐Jacobi, A., & Pereira, H. A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1284-4 · Cited by 114 · see citing works

Vanillic Acid, a Bioactive Phenolic Compound, Counteracts LPS-Induced Neurotoxicity by Regulating c-Jun N-Terminal Kinase in Mouse Brain

Ullah, R., Ikram, M. A., Park, T. J., Ahmad, R., Saeed, K. M., Alam, S. I., Rehman, I. U., Khan, A., Khan, I., Jo, M. G., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010361 · Cited by 112 · see citing works

RAGE: The Beneficial and Deleterious Effects by Diverse Mechanisms of Actions

Han, S.-H., Kim, Y. H., & Mook‐Jung, I. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0030-x · Cited by 109 · see citing works

The multiple faces of RAGE – opportunities for therapeutic intervention in aging and chronic disease

Ramasamy, R., Shekhtman, A. G., & Schmidt, A. M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1111873 · Cited by 110 · see citing works

Spatial memory impairments in a prediabetic rat model

Soares, E. F. P., Prediger, R. D., Nunes, S., de Castro, A. A., Viana, S., Lemos, C., Souza, C. M. D. A., Agostinho, P. M., Cunha, R. A., Carvalho, E., et al. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.055 · Cited by 105 · see citing works

RAGE Expression and ROS Generation in Neurons: Differentiation versus Damage

Piras, S., Furfaro, A. L., Domenicotti, C., Traverso, N., Marinari, U. M., Pronzato, M. A., & Nitti, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9348651 · Cited by 104 · see citing works

RAGE Expression in Human T Cells: A Link between Environmental Factors and Adaptive Immune Responses

Akirav, E. M., Preston‐Hurlburt, P., Garyu, J., Henegariu, O., Clynes, R., Schmidt, A. M., & Herold, K. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034698 · Cited by 102 · see citing works

RAGE mediates Aβ accumulation in a mouse model of Alzheimer’s disease via modulation of β- and γ-secretase activity

Fang, F., Yu, Q., Arancio, O., Chen, D., Gore, S. S., Yan, S. S., & Yan, S. F. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy017 · Cited by 103 · see citing works

Hesperidin attenuates learning and memory deficits in APP/PS1 mice through activation of Akt/Nrf2 signaling and inhibition of RAGE/NF-κB signaling

Hong, Y., & An, Z. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0662-z · Cited by 101 · see citing works

Advanced glycation end products enhance amyloid precursor protein expression by inducing reactive oxygen species

Ko, S., Lin, Y.-P., Lin, Y.-S., & Chang, S.-S. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.05.005 · Cited by 99 · see citing works

Blockage of CR1 prevents activation of rodent microglia

Crehan, H., Hardy, J., & Pocock, J. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.02.003 · Cited by 98 · see citing works

RAGE is a key cellular target for A -induced perturbation in Alzheimer s disease

Yan, S. S. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s265 · Cited by 97 · see citing works

Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits

Liu, R., Li, J.-Z., Song, J., Zhou, D., Huang, C., Bai, X., Xie, T., Zhang, X., Li, Y., Wu, C., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.031 · Cited by 96 · see citing works

Blood‐brain barrier development: Systems modeling and predictive toxicology

Saili, K. S., Zurlinden, T. J., Schwab, A. J., Silvin, A., Baker, N., Hunter, E. S., Ginhoux, F., & Knudsen, T. B. (2017) · Birth Defects Research · doi:10.1002/bdr2.1180 · Cited by 96 · see citing works

The Receptor for Advanced Glycation Endproducts (RAGE) and Mediation of Inflammatory Neurodegeneration

Derk, J., MacLean, M., Juranek, J., & Schmidt, A. M. (2018) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000421 · Cited by 96 · see citing works

Novel Disease-Modifying Therapies for Alzheimer's Disease

Jiang, T., Yu, J., & Tan, L. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120640 · Cited by 93 · see citing works

Multi-faced neuroprotective effects of geniposide depending on the RAGE-mediated signaling in an Alzheimer mouse model

Lv, C., Wang, L., Liu, X., Yan, S., Yan, S. S., Wang, Y., & Zhang, W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.09.019 · Cited by 93 · see citing works

Effects of RAGE-Specific Inhibitor FPS-ZM1 on Amyloid-β Metabolism and AGEs-Induced Inflammation and Oxidative Stress in Rat Hippocampus

Yan, H., Shen, C., Yin, Q., Sun, M., Ma, Y., & Liu, X. (2016) · Neurochemical Research · doi:10.1007/s11064-015-1814-8 · Cited by 93 · see citing works

Kidney, heart and brain: three organs targeted by ageing and glycation

Frimat, M., Daroux, M., Litke, R., Nevière, R., Tessier, F. J., & Boulanger, E. (2017) · Clinical Science · doi:10.1042/cs20160823 · Cited by 88 · see citing works

Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE) - and amyloid beta 1-42-induced signal transduction in glial cells

Slowik, A., Merres, J., Elfgen, A., Jansen, S., Mohr, F., Wruck, C., Pufe, T., & Brandenburg, L. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-55 · Cited by 87 · see citing works

High mobility group box-1 (HMGB1) is increased in injured mouse spinal cord and can elicit neurotoxic inflammation

Kigerl, K. A., Lai, W., Wallace, L. M., Yang, H., & Popovich, P. G. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.11.018 · Cited by 83 · see citing works

The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer’s Disease

Ogunmokun, G., Dewanjee, S., Chakraborty, P., Valupadas, C., Chaudhary, A., Kolli, V., Anand, U., Vallamkondu, J., Goel, P., Paluru, H. P. R., et al. (2021) · Cells · doi:10.3390/cells10102790 · Cited by 85 · see citing works

Increased neuronal PreP activity reduces Aβ accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer disease's mouse model

Du, F., Wang, Y., Zhang, Z., Du, H., Yan, S., Sun, Q., Zhong, C., Wu, L., Vangavaragu, J. R., Yan, S., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv241 · Cited by 86 · see citing works

Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid‐beta burden in Alzheimer’s disease models

Lee, S., Chu, K., Park, J., Jung, K., Jeon, D., Lim, J., Lee, S. K., Kim, M., & Roh, J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07534.x · Cited by 84 · see citing works

The Evolving Biology of Microglia in Alzheimer's Disease

Malm, T. M., Jay, T. R., & Landreth, G. E. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0316-8 · Cited by 74 · see citing works

Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics

Deardorff, W. J., & Grossberg, G. T. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1200972 · Cited by 80 · see citing works

High-Mobility Group Box-1 Protein and β-Amyloid Oligomers Promote Neuronal Differentiation of Adult Hippocampal Neural Progenitors via Receptor for Advanced Glycation End Products/Nuclear Factor-κB Axis: Relevance for Alzheimer's Disease

Meneghini, V., Bortolotto, V., Francese, M. T., Dellarole, A., Carraro, L., Terzieva, S., & Grilli, M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2052-12.2013 · Cited by 79 · see citing works

Role of Advanced Glycation on Aggregation and DNA Binding Properties of α-Synuclein

Padmaraju, V., Bhaskar, J. J., Rao, U. J. S. P., Salimath, P. V., & Rao, K. S. J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101965 · Cited by 78 · see citing works

Entorhinal Cortex dysfunction can be rescued by inhibition of microglial RAGE in an Alzheimer’s disease mouse model

Criscuolo, C., Fontebasso, V., Middei, S., Stazi, M., Ammassari‐Teule, M., Yan, S. S., & Origlia, N. (2017) · Scientific Reports · doi:10.1038/srep42370 · Cited by 75 · see citing works

Age-dependent accumulation of dicarbonyls and advanced glycation endproducts (AGEs) associates with mitochondrial stress

Akhter, F., Chen, D., Akhter, A., Yan, S. F., & Yan, S. S. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.021 · Cited by 77 · see citing works

The Effects of Dietary Advanced Glycation End-Products on Neurocognitive and Mental Disorders

D'Cunha, N. M., Sergi, D., Lane, M. M., Naumovski, N., Gamage, E., Rajendran, A., Kouvari, M., Gauci, S., Dissanayaka, T. D., Marx, W., et al. (2022) · Nutrients · doi:10.3390/nu14122421 · Cited by 80 · see citing works

Insulin resistance as the molecular link between diabetes and Alzheimer's disease

Abdalla, M. M. I. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i7.1430 · Cited by 82 · see citing works

Receptor for Advanced Glycation End Products (RAGE) on iNKT Cells Mediates Lung Ischemia–Reperfusion Injury

Sharma, A. K., LaPar, D. J., Stone, M. L., Zhao, Y., Kron, I. L., & Laubach, V. E. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12368 · Cited by 78 · see citing works

Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer’s disease

Walker, D. G., Lue, L. F., Paul, G., Patel, A., & Sabbagh, M. N. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1001490 · Cited by 77 · see citing works

RAGE is a key cellular target for A -induced perturbation in Alzheimer s disease

Yan, S. S. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/265 · Cited by 108 · see citing works

The importance of Ca2 Zn2 signaling S100 proteins and RAGE in translational medicine

Leclerc, E. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/223 · Cited by 77 · see citing works

Dissecting the Crosstalk between Endothelial Mitochondrial Damage, Vascular Inflammation, and Neurodegeneration in Cerebral Amyloid Angiopathy and Alzheimer’s Disease

Parodi‐Rullán, R. M., Javadov, S. A., & Fossati, S. (2021) · Cells · doi:10.3390/cells10112903 · Cited by 75 · see citing works

The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis

Azizi, G., & Mirshafiey, A. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2012.705292 · Cited by 72 · see citing works

Hypertension and Dementia: Epidemiological and Experimental Evidence Revealing a Detrimental Relationship

Perrotta, M., Lembo, G., & Carnevale, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030347 · Cited by 74 · see citing works

Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling

Adav, S. S., & Sze, S. K. (2016) · Molecular Brain · doi:10.1186/s13041-016-0272-9 · Cited by 72 · see citing works

Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer's disease

Olajide, O. J., Suvanto, M. E., & Chapman, C. A. (2021) · Biology Open · doi:10.1242/bio.056796 · Cited by 71 · see citing works

Alzheimer’s Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical Models

Carranza-Naval, M. J., Vargas-Soria, M., Hierro‐Bujalance, C., Baena‐Nieto, G., Garcı́a-Alloza, M., Infante‐Garcia, C., & del Marco, À. (2021) · Biomolecules · doi:10.3390/biom11020262 · Cited by 73 · see citing works

Microglia Ontology and Signaling

ElAli, A., & Rivest, S. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00072 · Cited by 73 · see citing works

Microglia Receptors in Animal Models of Traumatic Brain Injury

Younger, D., Murugan, M., Rao, K. V. R., Wu, L., & Chandra, N. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1428-7 · Cited by 69 · see citing works

Involvement of Microglial Receptor for Advanced Glycation Endproducts (RAGE) in Alzheimer's Disease: Identification of a Cellular Activation Mechanism

Lue, L.-F., Walker, D. G., Brachova, L., Beach, T. G., Rogers, J., Schmidt, A. M., Stern, D. M., & Yan, S. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7732 · Cited by 439 · see citing works

RAGE: A Potential Target for Aβ-Mediated Cellular Perturbation in Alzheimers Disease

Yan, S. F., Chen, X., Walker, D. G., Schmidt, A. M., Arancio, O., & Lue, L. (2007) · Current Molecular Medicine · doi:10.2174/156652407783220741 · Cited by 207 · see citing works

RAGE potentiates Aβ‐induced perturbation of neuronal function in transgenic mice

Arancio, O., Zhang, H. P., Chen, X., Lin, C., Trinchese, F., Puzzo, D., Liu, S., Hegde, A. N., Yan, S. F., Stern, A., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600415 · Cited by 328 · see citing works

The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.

Schmidt, A. M., Sahagan, B. G., Nelson, R. B., Selmer, J., Rothlein, R., & Bell, J. M. (2009) · PubMed · Cited by 86 · see citing works

RAGE and Alzheimer's Disease: A Progression Factor for Amyloid-β-Induced Cellular Perturbation?

Yan, S. D., Bierhaus, A., Nawroth, P. P., & Stern, D. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1030 · Cited by 179 · see citing works